The Centers for Disease Control and Prevention voted to authorize a third COVID-19 vaccine dose for immunocompromised people. This would afford individuals with vulnerable immune systems a higher degree of protection. (The Washington Post)
The Food and Drug Administration approved Jazz Pharmaceuticals’ Xywav, the first treatment approved for idiopathic hypersomnia. Critics, however, pointed out safety concerns around the drug, including its addictiveness. (Endpoints News)
Only about 23% of pregnant people were vaccinated as of the end of July, according to the CDC. Public health officials recently reiterated that vaccination is safe for anyone who is pregnant. (NPR)
YouTube, Facebook and other tech behemoths claim they have been combating health misinformation by actively sharing credible COVID-19 content. But the companies still struggle with cracking down on inaccurate information disseminated across their platforms. (STAT)
The CDC’s shifting guidance on masks has left Americans confused amid a surge in COVID-19 cases. Experts believe a simpler message – to wear masks in all indoor settings – would be more effective. (The New York Times)
